Tranylcypromine hemisulfate (Synonyms: 反苯环丙胺半硫酸盐; SKF 385 hemisulfate)
目录号: PL07508 纯度: ≥99%
CAS No. :13492-01-8
商品编号 规格 价格 会员价 是否有货 数量
PL07508-100mg 100mg ¥80.00 请登录
PL07508-250mg 250mg ¥165.00 请登录
PL07508-1g 1g ¥650.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Tranylcypromine hemisulfate
中文别名
硫酸反苯环丙胺;反苯环丙胺半硫酸盐;苯环丙胺硫酸盐;反苯环丙胺半硫酸盐 USP标准品;反式-2-苯基环丙胺 半硫酸盐;硫酸反苯环丙胺 标准品;反苯环丙胺
英文名称
Tranylcypromine hemisulfate
英文别名
Tranylcypromine Sulfate;TRANS-2-PHENYLCYCLOPROPYLAMINE HEMISULFATE SALT;(1R,2S)-rel-2-Phenylcyclopropanamine Sulfate;PHENYLCYCLOPROMINE SULFATE;TRANYLCYPROMINE HEMISULFATE;Tranylcypromine Hemisulfate (SKF trans-355, 2-PCPA, Parnate, Jatrosom);dl-Tranylcypromine hemisulfate;Tranylcypromine;parnate;tranylcyprominesulphate;TRANYLCYPROMINE HEMISULFATE SALT;Tranylcypromine Sulfate (125 mg);1-amino-2-phenylcyclopropanesulfate;trans,d,l-2-phenylcyclopropylaminesulfate;TRANS-2-PHENYLCYCLOPROPYLAMINE HEMISULFATE;tranylcyprominesulfate;phenylcycloprominesulfate;trans-2-Phenylcyclopropylamine hemisulfate salt;Tranylcypromine hemisulfate
Cas No.
13492-01-8
分子式
2[C9H11N].H2O4S
分子量
364.46
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Tranylcypromine (SKF 385) hemisulfate 是一种不可逆的非选择性单胺氧化酶 (MAO) 抑制剂,可用于研究抑郁症。Tranylcypromine hemisulfate 还是一种赖氨酸特异性脱甲基酶 1 (LSD1) 抑制剂,可抑制病变的生长并改善患有子宫内膜异位症的小鼠的全身痛觉过敏。
生物活性
Tranylcypromine (SKF 385) hemisulfate is an irreversible, nonselective monoamine oxidase (MAO) inhibitor used in the treatment of depression. Tranylcypromine hemisulfate is also a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis. Tranylcypromine has antidepressant effects.
性状
Solid
IC50 & Target[1][2]
KDM1/LSD1
体外研究(In Vitro)
Tranylcypromine (10 nM to 10 μM) exerts neuroprotective effects against toxicity induced by human Aβ(1-42) oligomers independently from the presence of glial cells. Tranylcypromine (100 μM) significantly protects RGCs from glutamate neurotoxicity-induced apoptosis as well as apoptosis induced by oxidative stress. Tranylcypromine promotes mitogen-activated protein kinase 12 (p38 MAPKγ) expression under conditions of glutamate (Glu)-induced stress. Besides, tranylcypromine contributes to RGC survival via alterations of p38 MAPKγ activity. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Tranylcypromine treatment significantly and substantially reduces the lesion size and improves generalized hyperalgesia in a dose-dependent fashion in mice with induced endometriosis. In addition, tranylcypromine treatment results in reduced immunoreactivity to biomarkers of proliferation, angiogenesis, and H3K4 methylation, leading to arrested EMT and lesion growth. Tranylcypromine (500 mM) injection exerts neuroprotective effects within intracellular apoptotic signaling pathways and suppresses morphologic changes in the retina of the rat, suppresses caspase 3 activity and recovers p38 MAPKγ expression in the retina after NMDA-induced injury, and enhances RGC survival after retinal injury via the attenuation of NMDA neurotoxicity. Tranylcypromine (10 μg/g) causes an approximate and significant doubling of labeled cells in the combined brain regions examined, as detected by Br
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Caraci F, et al. Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity. Eur J Pharmacol. 2015 Oct 5;764:256-263.
[2]. Sun Q, et al. Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis. Reprod Biol Endocrinol. 2016 Apr 9;14:17.
溶解度数据
In Vitro: H2O : 12.5 mg/mL (68.59 mM; Need ultrasonic)DMSO : 5 mg/mL (27.44 mM; ultrasonic and warming and heat to 60°C)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2